Comment on CMS-2026-1256-0002
Vizient, inc.OtherAdvocacy
Summary: Vizient, Inc., a healthcare performance improvement company, provides a mixed response to the proposed rule, offering several specific recommendations and objections across various policy areas. While they support some technical updates like the two-year mortality measurement period, they oppose several other proposals, including the repeal of certain technology add-on payment pathways and the mandatory reporting of specific quality measures without further testing.
Attached are the comments from Vizient, Inc on Medicare Program; Hospital Inpatient Prospective Payment Systems for Acute Care
Hospitals (IPPS) and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year (FY) 2027 Rates; Requirements for Quality Programs; and Other Policy Changes proposed rule